OMJ Pharmaceuticals, Inc. v. United States

753 F.3d 333, 2014 U.S. App. LEXIS 10414, 2014 WL 2462552
CourtCourt of Appeals for the First Circuit
DecidedJune 3, 2014
Docket13-1008
StatusPublished
Cited by2 cases

This text of 753 F.3d 333 (OMJ Pharmaceuticals, Inc. v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
OMJ Pharmaceuticals, Inc. v. United States, 753 F.3d 333, 2014 U.S. App. LEXIS 10414, 2014 WL 2462552 (1st Cir. 2014).

Opinion

KAYATTA, Circuit Judge.

From 1976 until 1996, section 936 of the Internal Revenue Code made available to U.S. corporations a tax credit fully offsetting the federal tax owed on income earned in the operation of any trade or business in Puerto Rico. In 1996, Congress enacted the Small Business Job Protection Act of 1996, Pub.L. No. 104-188, 110 Stat. 1755, setting in motion the complete repeal of section 936, ameliorated by a ten-year transition period during which the credit remained available only to taxpayers who had claimed it in previous years. During the final eight years of that transition period, the taxable income that an eligible claimant could take into account in computing its credit was capped at an amount roughly equal to the average of the amounts it had claimed in previous years. Though the cap was generally fixed, it could be adjusted up or down to account for a taxpayer’s purchases and sales of businesses that had themselves generated credit-eligible income. Thus, as the parties agree, if one U.S. corporation sold to a second U.S. corporation a business that accounted for $1 million in average prior year credit claims, the credit cap for the purchasing corporation would normally increase by $1 million, and the credit cap for the selling corporation would normally drop by the same amount.

This appeal requires us to decide, in a case of first impression, the effect on a U.S. taxpayer’s credit cap of a sale of a line of business in Puerto Rico to a foreign corporation that does not pay U.S. corporate income taxes. Having made three such sales, appellant OMJ Pharmaceuticals, Inc. (“OMJ”), argues that it was not required to reduce its cap by the amount of credit-eligible income associated with the lines of business sold because the buyer, as a foreign corporation, had no credit cap to increase or even establish. The *335 government disagrees, arguing that regardless of whether the purchaser of a line of business could increase or establish a credit cap, a seller was required to reduce its own cap by the amount associated with the line of business. On cross-motions for summary judgment, the district court sided with the government, rejecting OMJ’s claim for a tax refund of approximately $53 million. Because we read the controlling provisions of the Internal Revenue Code to require otherwise, we reverse and remand with instructions to enter summary judgment in OMJ’s favor.

I. Background

A. The Puerto Rico and Possessions Tax Credit

Between 1976 and 1996, Congress encouraged U.S. corporations to invest in Puerto Rico and other U.S. territories by establishing a possessions corporation system of taxation. Congress implemented that system primarily by creating the “Puerto Rico and possession tax credit,” codified in section 936 of the Internal Revenue Code. See generally Dep’t of the Treasury, The Operation and the Effect of the Possessions Corporation System of Taxation, Sixth Report (1989). As described by the Treasury Department:

The possessions corporation system of taxation is a set of rules under which a U.S. corporation deriving qualifying income from possessions and Puerto Rico pays no income tax to the United States. As a U.S. corporation, a possessions corporation is subject to federal tax on its worldwide income. However, a special credit available under section 936 fully offsets the federal tax on income from a trade or business in Puerto Rico and from qualified possession source investment income (QPSII). A U.S. parent corporation can, in turn, offset dividends received from a wholly owned 936 subsidiary with a 100 percent dividends-received deduction, which frees the dividend income from federal tax.

Id. at 5.

In 1996, Congress amended section 936 to terminate the credit, subject to certain transition rules. Small Business Job Protection Act of 1996, Pub.L. No. 104-188, § 1601, 110 Stat. 1755, 1827, 26 U.S.C. § 936 (amended 2007). Under the transition rules, an existing credit claimant— that is, a taxpayer who previously claimed the credit, § 936(j)(9) — could continue to claim the credit for up to ten years, § 936(j)(3). Beginning in the 1998 tax year, however, the amount of the credit became subject to a cap roughly equal to the annual average of a claimant’s inflation-adjusted possession income for the five taxable years immediately preceding 1995. See § 936(j)(2)(B), (3)(A), (4), (5).

Though the cap was based on past activity, it was not entirely fixed. Under certain circumstances, if a taxpayer acquired a trade or business that itself qualified for the credit, the acquiring taxpayer could add to its own cap the historic tax attributes of the acquired trade or business, enabling the acquiror’s new cap to reflect the historic credit-eligible expenditures of both entities. See § 936(j)(5)(D); accord H.R.Rep. No. 104-737, at 292 (1996) (Conf. Rep.) (“The adjusted base period income of the existing credit claimant from which the assets are acquired is divided between such corporation and the corporation that acquires such assets.”). The selling corporation would then subtract from its cap the same amounts.

B. OMJ’s Transactions

OMJ is a Delaware corporation that (among other things) develops, manufactures, and distributes healthcare products. Its principal place of business is Puerto Rico. Between 1993 and 1998, OMJ report *336 ed income from manufacturing operations in Puerto Rico. The parties agree that throughout the period on which this litigation is focused, OMJ remained eligible to claim the section 936 credit.

On November 30,1998, OMJ transferred three of its wholly-owned subsidiaries— Janssen Ortho, LLC, Ortho Biologies, LLC, and Lifescan, LLC — to a fourth company. That fourth company, OMJ Ireland, Ltd. (“OMJ Ireland”), was an Irish corporation also owned entirely by OMJ. OMJ Ireland had never paid or been required to pay U.S. income taxes.

After the transfers, OMJ paid income tax for 1999 and 2000 in the amounts it would have owed had its credit cap been reduced by the amount associated with the three businesses it sold. Later, however, OMJ filed two amended returns, claiming a refund of $27,537,675 (which it later adjusted to $22,874,764) for 1999 and a refund of $37,928,839 (which it later adjusted to $30,094,104) for 2000, justifying each on the ground that the credit cap reduction was unnecessary. The Internal Revenue Service disagreed and denied the refunds. OMJ, in pursuit of its refund claims, filed this suit soon afterwards.

The district court, concluding that section 936 required a credit cap reduction upon the sale of any trade or business, no matter who the buyer, granted summary judgment to the United States. OMJ appealed.

II. Standard of Review

We review the district court’s grant of summary judgment de novo. Shafmaster v. United States, 707 F.3d 130, 135 (1st Cir.2013); see also Prokey v. Watkins, 942 F.2d 67

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
753 F.3d 333, 2014 U.S. App. LEXIS 10414, 2014 WL 2462552, Counsel Stack Legal Research, https://law.counselstack.com/opinion/omj-pharmaceuticals-inc-v-united-states-ca1-2014.